Neuropore Therapies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neuropore.com
A Study to Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Placebos (125 mg)
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Neuropore Therapies Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT03954600
- Locations
- 🇺🇸
Celerion, Inc, Tempe, Arizona, United States
Phase 1 Study of NPT200-11 in Healthy Subjects
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- Neuropore Therapies Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02606682
- Locations
- 🇺🇸
Celerion, Inc, Tempe, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath